These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 11733217)

  • 1. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.
    Butterfield DA; Drake J; Pocernich C; Castegna A
    Trends Mol Med; 2001 Dec; 7(12):548-54. PubMed ID: 11733217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
    Butterfield DA; Lauderback CM
    Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
    Butterfield DA; Castegna A; Lauderback CM; Drake J
    Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
    Butterfield DA; Kanski J
    Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.
    Yatin SM; Aksenov M; Butterfield DA
    Neurochem Res; 1999 Mar; 24(3):427-35. PubMed ID: 10215518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences.
    Butterfield DA
    Curr Med Chem; 2003 Dec; 10(24):2651-9. PubMed ID: 14529455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease.
    Butterfield DA; Koppal T; Subramaniam R; Yatin S
    Rev Neurosci; 1999; 10(2):141-9. PubMed ID: 10658956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.
    Lauderback CM; Kanski J; Hackett JM; Maeda N; Kindy MS; Butterfield DA
    Brain Res; 2002 Jan; 924(1):90-7. PubMed ID: 11743999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
    Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA
    Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress hypothesis in Alzheimer's disease.
    Markesbery WR
    Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease.
    Butterfield DA; Yatin SM; Varadarajan S; Koppal T
    Methods Enzymol; 1999; 309():746-68. PubMed ID: 10507060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
    Yatin SM; Varadarajan S; Link CD; Butterfield DA
    Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
    Butterfield DA; Howard B; Yatin S; Koppal T; Drake J; Hensley K; Aksenov M; Aksenova M; Subramaniam R; Varadarajan S; Harris-White ME; Pedigo NW; Carney JM
    Life Sci; 1999; 65(18-19):1883-92. PubMed ID: 10576432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders.
    Ansari MA; Joshi G; Huang Q; Opii WO; Abdul HM; Sultana R; Butterfield DA
    Free Radic Biol Med; 2006 Dec; 41(11):1694-703. PubMed ID: 17145558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.